NIPH Clinical Trials Search

UMIN ID: UMIN000000781

Registered date:01/08/2007

Randomized phase II trial of adjuvant chemotherapy (CBDCA+GEM vs TS1+DTX) for completely resected non-small cell lung cancer

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiednon-small cell lung cancer
Date of first enrollment2007/08/01
Target sample size120
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)adjuvant chemotherapy with CBDCA+GEM adjuvant chemotherapy with TS1+DTX


Primary Outcome2-year relapse free survival
Secondary Outcometoxicity

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum76years-old
GenderMale and Female
Include criteria
Exclude criteriasymptomatic interstitial pneumonia multiple lung cancer or other-type cancer within 5 years severe organ failure past history of radiotherapy or chemotherapy pregnant or expecting mother

Related Information


public contact
Name Chiaki Endo
Address 4-1Seiryo-machi, Aoba-ku, Sendai Japan
Telephone 022-717-8526
Affiliation Japanese Northern East Area Thoracic Surgery Study Group Central study center
scientific contact
Name Takao Tsushima
Address 53Honcho, Hirosaki, Aomori Japan
Telephone 0172-39-5074
Affiliation Hirosaki University Hospital Department of Thoracic Surgery